Drug Search Results

CS-19

Alternative Names: cs-19, cs19, cs 19
Latest Update: 2024-01-08
Latest Update Note: PubMed Publication

Product Description

Wild type ETEC strain expressing the colonization faction CS19, and LT and ST enterotoxins. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT00564863)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Large Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Cochlear
Company Location: NEW YORK NY 10271
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Diarrhea

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
CLTD5663	N/A	Completed	Hearing Loss	2018-10-10
CIR 240	P1	Completed	Diarrhea	2008-05-01

Recent News Events

Date	Type	Title
01/08/2024	PubMed	Mean performances, character associations and multi-environmental evaluation of chilli landraces in north western Himalayas.
11/27/2023	PubMed	Spatial transcriptomics reveals novel genes during the remodelling of the embryonic human arterial valves.
05/08/2023	News Article	Canada Silver Cobalt Begins Stripping at Castle East to Follow up on Silver and Gold Intercepts
05/02/2023	PubMed	Femoral posture during embryonic and early fetal development: An analysis using landmarks on the cartilaginous skeletons of ex vivo human specimens.
01/17/2023	News Article	Canada Silver Cobalt Discovers Significant Gold Mineralization at Both Castle East and Castle Underground Mine
03/02/2020	News Article	Castle East Gold Zone Southwest of High-Grade Silver Discovery Broadens After Big Step-Out

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions